iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) Trading Up 1.5% – Here’s What Happened

iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) shares traded up 1.5% during trading on Tuesday . The company traded as high as $31.45 and last traded at $31.17. 20,361 shares changed hands during trading, a decline of 48% from the average daily volume of 38,904 shares. The stock had previously closed at $30.70.

iShares Genomics Immunology and Healthcare ETF Price Performance

The firm has a market cap of $169.88 million, a P/E ratio of 14.76 and a beta of 0.96. The company’s 50 day moving average is $29.82 and its two-hundred day moving average is $28.94.

Institutional Trading of iShares Genomics Immunology and Healthcare ETF

A number of hedge funds have recently modified their holdings of IDNA. Portland Global Advisors LLC grew its holdings in shares of iShares Genomics Immunology and Healthcare ETF by 0.7% during the 3rd quarter. Portland Global Advisors LLC now owns 103,007 shares of the company’s stock worth $2,432,000 after purchasing an additional 684 shares in the last quarter. Ameriprise Financial Inc. increased its position in shares of iShares Genomics Immunology and Healthcare ETF by 8.4% during the third quarter. Ameriprise Financial Inc. now owns 71,473 shares of the company’s stock valued at $1,688,000 after purchasing an additional 5,540 shares during the period. Finally, Triumph Capital Management acquired a new position in shares of iShares Genomics Immunology and Healthcare ETF in the third quarter valued at $35,000.

iShares Genomics Immunology and Healthcare ETF Company Profile

The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is managed by BlackRock.